Last reviewed · How we verify
NCT06689007
FES Implementation Pediatrics
NA trial testing Implementation Intervention in Cerebral Palsy (CP) in 15 participants. Completed in 18 July 2025.
18 July 2025
Quick facts
| Lead sponsor | University Health Network, Toronto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 1 October 2024 |
| Primary completion | 18 July 2025 |
| Estimated completion | 18 July 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Implementation Intervention
Conditions studied
- Cerebral Palsy (CP) — all drugs for Cerebral Palsy (CP) →
Sponsor
University Health Network, Toronto
Who can join
Eligibility, any sex, with Cerebral Palsy (CP). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical rehabilitation interventions that promote activity-dependent neuroplasticity are desired for children with CP as this will result in improved motor skill and function. In adult neurological populations, such as stroke and spinal cord injury, FES is a recommended, evidence-based intervention that addresses motor and sensory impairments and promotes neuroplasticity. The evidence base supporting the safety, feasibility and efficacy of FES for youth with CP is rapidly growing, yet FES is not commonly used in Canadian pediatric rehabilitation. Through interviews with Canadian pediatric physical and occupational therapists, we identified numerous barriers to FES implementation, including a lack of knowledge and training in FES, difficulty accessing FES equipment, and a perceived lack of time to deliver FES within a treatment session. To address these barriers, we have developed an implementation intervention for FES that consists of an online course and toolkit for physical and occupational therapists. As a next step, we will evaluate the effects of the implementation intervention on pediatric therapists' knowledge, confidence and use of FES.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06689007
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Implementation Intervention
Trials testing the same drug.
- NCT05350878 — Implementing Mobile Technology for Unhealthy Alcohol Use · NA · completed
- NCT04796961 — Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics · NA · completed
Other recruiting trials for Cerebral Palsy (CP)
Currently open trials in the same condition.
- NCT07587476 — Constraint-induced Movement Therapy Combined With Functional Electrical Stimulation in Children With Cerebral Palsy · NA · recruiting
- NCT07500896 — Effects of an Intensive Rhythmic Dance Program on Learning Skills in Children With Cerebral Palsy · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07377201 — Childhood Toxin Perception Survey · recruiting
- NCT07311018 — Neuromuscular Electrical Stimulation and Leap Motion-Based Exercises in Cerebral Palsy · NA · recruiting
Other University Health Network, Toronto trials
Trials by the same sponsor.
- NCT06831032 — Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response · NA · recruiting
- NCT06634056 — Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients U · Phase 2 · not yet recruiting
- NCT06836726 — Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resis · Phase 2 · not yet recruiting
- NCT07515651 — Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas · Phase 2 · not yet recruiting
- NCT07509450 — Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cel · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06689007 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Health Network, Toronto
- Last refreshed: 23 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06689007.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing